Latest Breaking News On - Susheel umesh - Page 2 : comparemela.com

Biocon Biologics Expands Footprint in Emerging Markets

Biocon Biologics Expands Footprint in Emerging Markets
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

Susheel umeshTrastuzumab ogivriAdalimumab hulioPegfilgrastim fulphilaShreehas tambeGlargine semgleeBevacizumab abevmyBiocon biologicsBiocon ltdBiocon biologics ltdBiocon biologics expands footprintBiologics ltdEmerging marketsBiocon biologicChief commercial officerBiocon limited

Biocon Biologics completes integration of biosimilars business in 70+ emerging markets

Biocon Biologics completes integration of biosimilars business in 70+ emerging markets
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Shreehas tambeSusheel umeshBiocon biologicsBiocon biologicManaging directorChief commercial officerEmerging markets

Biocon Foundation Celebrates the Spirit of Har Ghar Tiranga | India Education | Latest Education News | Global Educational News

Biocon Foundation Celebrates the Spirit of Har Ghar Tiranga | India Education | Latest Education News | Global Educational News
indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.

Seema ahujaAzadi ka amrit mahotsavMukesh kamathBiocon biologicsKenneth barrKiran mazumdar shawShwetha baiSusheel umeshAzadi ka mahotsavAnupama narayan shettyHar ghar tirangaHennagara panchayataNarendra modiMuniratna munirajuRavi kumarSunil koteel

Biocon Biologics Insugen awarded a 3-year contract by Ministry of Health, Malaysia

Biocon Biologics’ Insugen awarded a 3-year contract by Ministry of Health, Malaysia

United statesSusheel umeshBiocon sdnBiocon biologicsMinistry of healthMinistry of health moNational pharmaceutical regulatory authorityBiocon biologics limitedDuopharma marketingDuopharma biotechBiologic insugenChief commercial officerEmerging marketsMiddle eastLatin americaBiocon biologics insugen

Biocon Biologics provided 7,000 doses of Itolizumab in April

The company does not look at Covid-19 related drugs as a business opportunity; it expects higher growth this fiscal year on the back of new biosimilar launches in both emerging and developed markets, Arun Chandavarkar, managing director of Biocon Biologics, told ET in an interview.

Arun chandavarkarShreehas tambeSusheel umeshBiocon biologicsCovid 19அருண் சாண்டவர்கள்சுஷீல் உமேஷ்பயோகான் உயிரியல்